Key result
Oral ranolazine significantly improved global left ventricular function (P < .0001), including both diastolic and systolic parameters, in patients with stable angina.
Why the study?
Does oral ranolazine improve left ventricular function in patients with stable angina?
Does oral ranolazine improve left ventricular function in patients with stable angina?
Oral ranolazine significantly improves global left ventricular systolic and diastolic function in patients with stable angina.
No takes yet. Share an insight, caveat, or question.
May support ranolazine evaluation for LV function in stable angina; hypothesis-generating and should not change practice without RCTs.
Figueredo et al. (2010) studied this question. Oral ranolazine significantly improved global left ventricular function (P < .0001), including both diastolic and systolic parameters, in patients with stable angina.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: